Publications & Presentations

We would like to thank our patients for their participation in research studies. Your contribution has made a lasting impact on the field and will advance the care of future patients!

Selected Publications and Presentations

• Racial and Ethnic Distribution of Rheumatic Diseases in Health Systems of the National Patient-Centered Clinical Research Network
• A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study
• Use of the BASDAI in Psoriatic Arthritis Patients With and Without Axial Disease
• The impact of dietary interventions in psoriatic arthritis
• H. Ralph Schumacher
• Corticosteroid Injections for Symptomatic Treatment of Osteoarthritis of the Knee: A Pilot Blinded Randomized Trial
• Associations between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis
• Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
• Changes in Patterns of Use of Advanced Therapies Following Emerging Data About Adverse Events in Patients With Rheumatoid Arthritis From the Veterans Affairs Health System
• Identifying Factors Associated With Treatment Response in Rheumatoid Arthritis Clinical Trials
• Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study

PubMed Feed

• Frailty and Risk of Serious Infections in Patients With Rheumatoid Arthritis Treated With Biologic or Targeted-Synthetic Disease-Modifying Antirheumatic Drugs.
  Arthritis care & research. 2024 May;76(5):627-635 Epub 2024 Feb 4; Authors: Singh N, Gold LS, Lee J, Wysham KD, Andrews JS, Makris UE, England BR, George MD, Baker JF, Jarvik J, Heagerty PJ, Singh S

• Prevalence of Cardiovascular and Cancer Risk Factors Among Rheumatoid Arthritis Patients Prescribed JAKi and TNFi: A MarketScan by Merative Cross-Sectional Study.
  Arthritis care & research. 2024 Apr 29; Authors: Janak JC, Ross RD, Brady BL, Palmer L, Howard JT, Baker JF

• Using Electronic Health Records and Linked Claims Data to Assess New Medication Use and Primary Nonadherence in Rheumatology Patients.
  Arthritis care & research. 2024 Apr;76(4):550-558 Epub 2024 Jan 18; Authors: Beukelman T, Su Y, Xie F, George MD, England BR, Curtis C, Clinton C, Stewart P, Curtis JR

• Changes in Characteristics of Patients Initiating and Discontinuing Advanced Therapies for Rheumatoid Arthritis Following the Release of Safety Data.
  Arthritis care & research. 2024 Apr;76(4):463-469 Epub 2024 Jan 12; Authors: Song S, England BR, Sauer B, George MD, Riley TR, Wallace B, Cannon GW, Mikuls TR, Baker JF

• Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
  Rheumatology and therapy. 2024 Apr;11(2):313-329 Epub 2024 Jan 22; Authors: Mease PJ, Young P, Fallon L, Mundayat R, Dina O, Blachley T, Middaugh N, Ogdie A

• Combined Orbital and Cranial Vessel Wall Magnetic Resonance Imaging for the Assessment of Disease Activity in Giant Cell Arteritis.
  ACR open rheumatology. 2024 Apr;6(4):189-200 Epub 2024 Jan 24; Authors: Rhee RL, Rebello R, Tamhankar MA, Banerjee S, Liu F, Cao Q, Kurtz R, Baker JF, Fan Z, Bhatt V, Amudala N, Chou S, Liang R, Sanchez M, Burke M, Desiderio L, Loevner LA, Morris JS, Merkel PA, Song JW

• Real-World Use and Effectiveness Outcomes in Patients with Rheumatoid Arthritis Treated with Upadacitinib: An Analysis from the CorEvitas Registry.
  Rheumatology and therapy. 2024 Apr;11(2):363-380 Epub 2024 Feb 12; Authors: Baker JF, Zueger P, Ali M, Bennett D, Yu M, Munoz Maldonado Y, McLean RR

• Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial.
  Arthritis care & research. 2024 Mar 26; Authors: Strand V, Gossec L, Coates LC, Ogdie A, Choi J, Becker B, Zhuo J, Lehman T, Nowak M, Elegbe A, Mease PJ, Deodhar A

• Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting.
  Rheumatology and therapy. 2024 Mar 20; Authors: Baker JF, Bakewell C, Dikranian A, Lam G, O'Brien J, Moore PC, Yu M, Hur P, Masri KR

• Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis.
  Annals of the rheumatic diseases. 2024 Mar 12;83(4):429-436; Authors: Baker JF, ODell JR, England BR, Giles JT, Newcomb JA, George MD, Thiele G, Moreland L, Bridges SL, Curtis JR, Mikuls TR